ArticleFluids and barriers of the CNS2025
Comparative permeability of the blood-brain barrier to albumin, DTPA, and sucrose: effects of inflammation-induced disruption.
Article in Fluids and barriers of the CNS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Detection of inflammation-related blood-brain barrier dysfunction using PET and MR imaging: a pilot study.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Blood-brain barrier (BBB) disruptions are increasingly recognized in a wide range of diseases and conditions, resulting in a need to detect and quantitate such disruptions. In humans, gadolinium (Gd)-labeled compounds including diethylenetriaminepentaacetic acid (Gd-DTPA) as detected by magnetic resonance imaging (MRI) and technetium (99mTc) labeled-DTPA as detected by single photon emission computed tomography (SPECT) are commonly used, whereas 14C-sucrose, 99mTc-DTPA, and radioactively labeled albumin are commonly used in animals. How these agents compare to one another and in different species has seldom been investigated, making comparisons between human and animal studies difficult. Here, we compared the three agents of radioactively labeled albumin, 99mTc-DTPA, and 14C-sucrose in monolayers of human induced pluripotent stem cell (iPSC)-derived brain endothelial-like cells (iBECs), in control mice, and in mice whose BBB was disrupted by one or three doses of the inflammatory agent lipopolysaccharide (LPS). In iBECs, all three agents crossed with permeation dramatically decreasing as transendothelial electrical resistance (TEER) increased. Permeation of sucrose and DTPA were nearly identical with albumin being 10–20 times less permeable at all levels of TEER. In mice with an intact BBB, penetration of sucrose across the BBB was 2–15 times greater than DTPA, which was about 5.5 times greater than penetration of albumin (sucrose > DTPA > albumin). Uptake was about twice baseline levels for each of these agents in the 3 dose LPS (more inflamed) mice. However, in the one dose LPS (less inflamed) mice, sucrose more readily showed BBB disruption than did DTPA and DTPA more readily showed disruption than albumin (sucrose > DTPA > albumin). Linear regression analysis showed good correlations between BBB disruption as measured between albumin and DTPA (r = 0.783) and between DTPA and sucrose (r = 0.623). However, Bland-Altman analysis showed discordance between albumin and DTPA in the mice with the greatest disruption. Bland-Altman analysis also showed that disruption to sucrose was greater at any given level of inflammation than to DTPA. These subtle differences support the view that the BBB can become disrupted in different ways and that agents, which differ in size and/or structure, may vary subtly in the type or mechanism of disruption that they measure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.